Search
Search Results
##search.searchResults.foundPlural##
-
NURSES’ PHYSICAL AND PSYCHOLOGICAL SYMPTOMS DURING THE FIRST COVID-19 LOCKDOWN IN ITALY A nationwide cross-sectional study in stem cell transplantation setting.
1940PDF: 831HTML: 229 -
ARA-C, IDARUBICINE AND GENTUZUMAB OZOGAMICIN (AIM) AS SALVAGE TREATMENT IN ADVANCED ACUTE MYELOID LEUKEMIA PATIENTS
1702PDF: 819HTML: 938cover letter: 274 -
WALDENSTROM’S MACROGLOBULINEMIA: AN UPDATE
7657PDF: 2442HTML: 1740Table 1.: 214Table 2.: 224Table 3.: 208Table 4.: 209 -
TREATMENT OF ADVANCED SYSTEMIC MASTOCYTOSIS WITH MIDOSTAURIN: PRACTICAL GUIDANCE FOR OPTIMAL THERAPY AND MANAGEMENT Advanced systemic mastocytosis and midostaurin
1264PDF: 1015HTML: 224 -
DETECTION OF ANTINUCLEAR ANTIBODIES TARGETING INTRACELLULAR SIGNAL TRANSDUCTION, METABOLISM, APOPTOTIC PROCESSES AND CELL DEATH IN CRITICAL COVID-19 PATIENTS
1375PDF: 1019HTML: 349Suppl. Figure: 184Suppl. Tables: 207 -
SARS-CoV-2 INFECTED PATIENTS: FROM A HEMATOLOGIST PERSPECTIVE COVID-19 and Hematology
1090PDF: 968HTML: 340 -
Aberrant acquisition of T-cell associated markers in plasma cell neoplasms: An aggressive disease with extramedullary involvement and very short survival Aberrant T markers on malignant plasma cells
1585PDF: 400HTML: 214 -
INFECTIONS AND FOLLICULAR LYMPHOMA: IS THERE A LINK?
3255PDF: 1022HTML: 2032 -
MONITORING THE RESPONSE TO TYROSINE KINASE INHIBITOR (TKI) TREATMENT IN CHRONIC MYELOID LEUKEMIA (CML)
4023PDF: 1528HTML: 9192Untitled: 284Untitled: 191Untitled: 175Untitled: 168Untitled: 193Untitled: 347 -
-
AUTOIMMUNE CYTOPENIAS IN CHRONIC LYMPHOCYTIC LEUKEMIA, FACTS AND MYTHS
2221PDF: 1208HTML: 3871 -
Sterile "Abscess" of the Spleen and the Sickle Cell Trait
2892PDF: 700HTML: 824 -
IMPORTANCE OF CLASSICAL MORPHOLOGY IN THE DIAGNOSIS OF MYELODYSPLASTIC SYNDROME
3363PDF: 2283HTML: 23348Untitled: 208Untitled: 220Untitled: 238 -
COAGULOPATHY IN BETA-THALASSEMIA: CURRENT UNDERSTANDING AND FUTURE PERSPECTIVES
1129PDF: 488HTML: 8185 -
PERPHERAL BLOOD CELL MITOCHONDRIAL DYSFUNCTION IN MYELODYSPLASTIC SYNDROMECAN BE IMPROVED BY A COMBINATION OF COENZYME Q10 AND CARNITINE Blood cell mitochondrial dysfunction in myelodysplastic syndrome
1127PDF: 774HTML: 316 -
ENDOTHELIAL BIOMARKERS IN PATIENTS RECOVERED FROM COVID-19 ONE YEAR AFTER HOSPITAL DISCHARGE: A CROSS-SECTIONAL STUDY Endothelial biomarkers in COVID-19 recoverers one year after hospital discharge.
1315PDF: 734HTML: 330 -
Cytomorphology of Chimeric Antigen Receptor T-Cells (CAR-T)
1243PDF: 534HTML: 227 -
ACUTE LUNG INJURY COMPLICATING BLOOD TRANSFUSION IN POST-PARTUM HEMORRHAGE: INCIDENCE AND RISK FACTORS.
2474PDF: 1248HTML: 3608Acute lung injury complicating blood transfusion in post-partum hemorrhage: incidence and risk factors.: 414 -
Multiple myeloma diagnosed by CT-guided rib biopsy after a hemodilute bone marrow aspirate, in a patient with a biclonal pattern on serum protein electrophoresis Multiple Myeloma diagnosed with CT-guided rib biopsy
151PDF: 63HTML: 4 -
THE BIOLOGY OF MYCOBACTERIUM TUBERCULOSIS INFECTION.
10704PDF: 6420HTML: 21809 -
RELIABILITY OF DIFFERENT RBC INDICES AND FORMULAS IN DISCRIMINATING BETWEEN ?-THALASSEMIA MINOR AND OTHER CAUSES OF MICROCYTIC HYPOCHROMIC ANEMIA
2056PDF: 1644HTML: 14651Untitled: 215Untitled: 181 -
PREVALENCE OF HEPATITIS B, HEPATITIS C AND HIV IN MULTIPLY TRANSFUSED SICKLE CELL DISEASE PATIENTS FROM OMAN HBV,HCV and HIV and Sickle Cell Disease.
1655PDF: 1006HTML: 369 -
SOCIOECONOMIC STATUS IS GLOBALLY A PROGNOSTIC FACTOR FOR OVERALL SURVIVAL OF MULTIPLE MYELOMA PATIENTS; SYNTHESIS OF STUDIES AND REVIEW OF THE LITERATURE SES as prognostic factor for myeloma survival
2057PDF: 846HTML: 259 -
HEMATOLOGY PATIENT PROTECTION DURING THE COVID-19 PANDEMIC IN ITALY: A NATIONWIDE NURSING SURVEY Hematology patient protection during the COVID-19
1641PDF: 595HTML: 232







